Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSV-1 gD.

Sciortino MT, Medici MA, Marino-Merlo F, Zaccaria D, Giuffrè-Cuculletto M, Venuti A, Grelli S, Bramanti P, Mastino A.

Biochem Pharmacol. 2008 Dec 1;76(11):1522-32. doi: 10.1016/j.bcp.2008.07.030. Epub 2008 Aug 3.

PMID:
18723002
2.

Involvement of HVEM receptor in activation of nuclear factor kappaB by herpes simplex virus 1 glycoprotein D.

Sciortino MT, Medici MA, Marino-Merlo F, Zaccaria D, Giuffrè-Cuculletto M, Venuti A, Grelli S, Mastino A.

Cell Microbiol. 2008 Nov;10(11):2297-311. doi: 10.1111/j.1462-5822.2008.01212.x. Epub 2008 Aug 15.

PMID:
18671825
3.

Signaling pathway used by HSV-1 to induce NF-kappaB activation: possible role of herpes virus entry receptor A.

Teresa Sciortino M, Medici MA, Marino-Merlo F, Zaccaria D, Giuffrè M, Venuti A, Grelli S, Mastino A.

Ann N Y Acad Sci. 2007 Jan;1096:89-96.

PMID:
17405920
4.

Herpes simplex virus type 1 glycoprotein D inhibits T-cell proliferation.

La S, Kim J, Kwon BS, Kwon B.

Mol Cells. 2002 Dec 31;14(3):398-403.

5.
7.

Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.

Nicola AV, Ponce de Leon M, Xu R, Hou W, Whitbeck JC, Krummenacher C, Montgomery RI, Spear PG, Eisenberg RJ, Cohen GH.

J Virol. 1998 May;72(5):3595-601.

8.

Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.

Roller DG, Dollery SJ, Doyle JL, Nicola AV.

Virology. 2008 Dec 20;382(2):207-16. doi: 10.1016/j.virol.2008.09.015. Epub 2008 Oct 23.

9.

Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.

Krummenacher C, Baribaud F, Ponce de Leon M, Baribaud I, Whitbeck JC, Xu R, Cohen GH, Eisenberg RJ.

Virology. 2004 May 1;322(2):286-99.

10.

HSV and glycoprotein J inhibit caspase activation and apoptosis induced by granzyme B or Fas.

Jerome KR, Chen Z, Lang R, Torres MR, Hofmeister J, Smith S, Fox R, Froelich CJ, Corey L.

J Immunol. 2001 Oct 1;167(7):3928-35.

11.

Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.

Wang K, Tomaras GD, Jegaskanda S, Moody MA, Liao HX, Goodman KN, Berman PW, Rerks-Ngarm S, Pitisuttithum P, Nitayapan S, Kaewkungwal J, Haynes BF, Cohen JI.

J Virol. 2017 Sep 12;91(19). pii: e00411-17. doi: 10.1128/JVI.00411-17. Print 2017 Oct 1.

12.

Contributions of gD receptors and glycosaminoglycan sulfation to cell fusion mediated by herpes simplex virus 1.

Terry-Allison T, Montgomery RI, Warner MS, Geraghty RJ, Spear PG.

Virus Res. 2001 Apr;74(1-2):39-45.

PMID:
11226572
13.

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.

Montgomery RI, Warner MS, Lum BJ, Spear PG.

Cell. 1996 Nov 1;87(3):427-36.

15.

Herpes simplex virus entry mediator associates in infected cells in a complex with viral proteins gD and at least gH.

Perez-Romero P, Perez A, Capul A, Montgomery R, Fuller AO.

J Virol. 2005 Apr;79(7):4540-4.

16.

Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry.

Whitbeck JC, Peng C, Lou H, Xu R, Willis SH, Ponce de Leon M, Peng T, Nicola AV, Montgomery RI, Warner MS, Soulika AM, Spruce LA, Moore WT, Lambris JD, Spear PG, Cohen GH, Eisenberg RJ.

J Virol. 1997 Aug;71(8):6083-93.

17.

Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition.

Stiles KM, Whitbeck JC, Lou H, Cohen GH, Eisenberg RJ, Krummenacher C.

J Virol. 2010 Nov;84(22):11646-60. doi: 10.1128/JVI.01550-10. Epub 2010 Sep 8.

18.

Enhanced resistance to herpes simplex virus type 1 infection in transgenic mice expressing a soluble form of herpesvirus entry mediator.

Ono E, Yoshino S, Amagai K, Taharaguchi S, Kimura C, Morimoto J, Inobe M, Uenishi T, Uede T.

Virology. 2004 Mar 15;320(2):267-75.

19.
20.

Structural basis for the antibody neutralization of herpes simplex virus.

Lee CC, Lin LL, Chan WE, Ko TP, Lai JS, Wang AH.

Acta Crystallogr D Biol Crystallogr. 2013 Oct;69(Pt 10):1935-45. doi: 10.1107/S0907444913016776. Epub 2013 Sep 20.

Supplemental Content

Support Center